EQ Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$1.12K 62
2025
Q4
$1.12K Buy
+100
New +$1.14K ﹤0.01% 231
2025
Q3
Sell
-100
Closed -$1.22K 63
2025
Q2
$1.22K Hold
100
﹤0.01% 205
2025
Q1
$1.43K Buy
+100
New +$1.56K ﹤0.01% 216

Other funds holding AVNS

EQ Wealth Advisors's AVNS Position: Q1 2026 in Review

EQ Wealth Advisors sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 100 shares — an estimated $1.12K sold.

EQ Wealth Advisors first reported a position in AVNS in Q1 2025 and held it in 3 quarters. The position peaked at $1.43K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • EQ Wealth Advisors reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • EQ Wealth Advisors sold 100 Avanos Medical shares in Q1 2026, an estimated $1.12K.
  • EQ Wealth Advisors first reported a position in Avanos Medical in Q1 2025 and held it in 3 quarters.
  • EQ Wealth Advisors's Avanos Medical position peaked at $1.43K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on EQ Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.